USP48 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.341400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.223000E-01
Normal-vs-Stage2
4.791800E-01
Normal-vs-Stage3
1.651020E-01
Normal-vs-Stage4
5.366800E-01
Stage1-vs-Stage2
3.766000E-01
Stage1-vs-Stage3
2.714600E-01
Stage1-vs-Stage4
5.323500E-02
Stage2-vs-Stage3
8.168300E-02
Stage2-vs-Stage4
2.620300E-02
Stage3-vs-Stage4
3.264200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.642800E-01
Normal-vs-AfricanAmerican
7.235400E-01
Normal-vs-Asian
1.862610E-01
Caucasian-vs-AfricanAmerican
8.032800E-01
Caucasian-vs-Asian
1.436000E-01
AfricanAmerican-vs-Asian
2.596200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.009800E-01
Normal-vs-Female
5.042800E-01
Male-vs-Female
6.007400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.815200E-01
Normal-vs-Age(41-60Yrs)
8.008200E-01
Normal-vs-Age(61-80Yrs)
3.670000E-01
Normal-vs-Age(81-100Yrs)
8.220400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.058400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.237600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.005800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.960170E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.663800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.923800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.952000E-01
Normal-vs-Daily Drinker
6.142200E-01
Normal-vs-Weekly Drinker
3.000400E-01
Normal-vs-Occasional Drinker
9.190800E-01
Normal-vs-Social Drinker
5.254000E-01
Non Drinker-vs-Daily Drinker
1.847570E-01
Non Drinker-vs-Weekly Drinker
5.876800E-01
Non Drinker-vs-Occasional Drinker
4.621300E-03
Non Drinker-vs-Social Drinker
1.751160E-01
Daily Drinker-vs-Weekly Drinker
5.105200E-01
Daily Drinker-vs-Occasional Drinker
2.074800E-01
Daily Drinker-vs-Social Drinker
9.923000E-01
Weekly Drinker-vs-Occasional Drinker
4.069900E-02
Weekly Drinker-vs-Social Drinker
4.449200E-01
Occasional Drinker-vs-Social Drinker
1.693610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.518600E-01
Normal-vs-Grade 2
7.638200E-02
Normal-vs-Grade 3
8.096100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.553600E-02
Grade 1-vs-Grade 3
8.534300E-02
Grade 1-vs-Grade 4
2.518600E-01
Grade 2-vs-Grade 3
7.487000E-01
Grade 2-vs-Grade 4
7.638200E-02
Grade 3-vs-Grade 4
8.096100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.997200E-01
Normal-vs-NonDiabetic
3.711200E-01
Diabetic-vs-NonDiabetic
8.495400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.978600E-01
Normal-vs-NoPancreatitis
3.878600E-01
Pancreatitis-vs-NoPancreatitis
6.823600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.864400E-01
Normal-vs-N1
4.930200E-01
N0-vs-N1
4.293600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.990200E-01
Normal-vs-TP53-NonMutant
4.646000E-01
TP53-Mutant-vs-TP53-NonMutant
1.183630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
